Myasthenia Gravis: Diagnosis and Treatment-Reference-Cited by-同舟云学术

Myasthenia Gravis: Diagnosis and Treatment

Published:2003-02 Issue:2 Volume:15 Page:72-78
ISSN:1041-2972
Container-title:Journal of the American Academy of Nurse Practitioners
language:en
Short-container-title:Journal of the American Academy of Nurse Practitioners

Author:

Armstrong Shannon Mortensen¹,Schumann Lorna²

Affiliation:

1. Shannon Mortensen Armstrong, MSN, NP‐C, APPN, is an instructor at the Intercollegiate College of Nursing (ICN) and a Family Nurse Practitioner in Spokane, WA.

2. Lorna Schumann, PhD, FAANP, FNP, ACNP, is an Associate Professor of Nursing ICN and ICU staff nurse at Valley Hospital in Spokane, WA. Contact Ms. Armstrong by e‐mail at

Publisher

Wiley

Subject

General Nursing

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1745-7599.2003.tb00354.x

Reference26 articles.

1. Current Medical Diagnosis & Treatment 2003 Appleton & Lange M.J. Aminoff L.M. Tierney S.J. McPhee M.A. Papadakis Nervous system 946 1005

2. Crisis: Myasthenia Gravis

3. Pathophysiology: Biological and Behavioral Perspectives 2000 W.B. Saunders J.L Banasik LE. Copstead J.L Banasik Inflammation and immunity 184 218

4. Mortality and survival in myasthenia gravis: a Danish population based study

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perspective Chapter: Specific predictors of the autoimmune reactions formation in case of immunocompetent organs damage in patients with myasthenia gravis and hepatosplenomegaly;Causes and Diagnosis of Autoimmune Diseases [Working Title];2023-12-15

2. Neurological Adverse Events Induced by Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer: Current Perspectives and New Development;Clinical Medicine Insights: Oncology;2021-01

3. Myasthenia Gravis;Journal of Gerontological Nursing;2013-12